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The physical properties of the lamellar lipid-bilayer component of biological membranes are controlled
by a host of thermodynamic forces leading to overall tensionless bilayers with a conspicuous lateral
pressure proﬁle and build-in curvature-stress instabilities that may be released locally or globally in terms
of morphological changes. In particular, the average molecular shape and the propensity of the different
lipid and protein species for forming non-lamellar and curved structures are a source of structural
transitions and control of biological function. The effects of different lipids, sterols, and proteins on
membrane structure are discussed and it is shown how one can take advantage of the curvature-stress
modulations brought about by speciﬁc molecular agents, such as fatty acids, lysolipids, and other
amphiphilic solutes, to construct intelligent drug-delivery systems that function by enzymatic
triggering via curvature.
Practical applications: The simple concept of lipid molecular shape and how it impacts on the
structure of lipid aggregates, in particular the curvature and curvature stress in lipid bilayers and
liposomes, can be exploited to construct liposome-based drug-delivery systems, e.g., for use as nano-
medicine in cancer therapy. Non-lamellar-forming lysolipids and fatty acids, some of which may be
designed to be prodrugs, can be created by phospholipase action in diseased tissues thereby providing for
targeted drug release and proliferation of molecular entities with conical shape that break down the
permeability barrier of the target cells and may hence enhance efﬁcacy.
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1 Introduction
Our picture of lipid membranes has come a long way since
Gorter and Grendel in 1925 formulated the lipid-bilayer
hypothesis [1–3]. Most textbook models of membranes are
still based on the celebrated ﬂuid-mosaic Singer–Nicolson
modelfrom1972[4–6],althoughwehaveinrecentyearsseen
signiﬁcant amendments to this model, not least fuelled by the
ﬁnding of lipid membrane domains in both model mem-
branes and cells [7–12] and the subsequent ‘‘raft rush’’
[13–17]. The science of lipidology has now become an estab-
lished discipline, acknowledging that lipids organize in space
and time and display emergent physico-chemical properties
that are beyond the chemical nature of the individual mol-
ecules and which collectively control membrane function [8].
Recently, lipidomics has followed as a new science in the
omics-sequel, characterized by an explosion in detailed data
for lipid proﬁles of tissues, cells, and subcellular components
[18]. The focus is now swinging toward enumerating indi-
vidual lipid species, determining their identity, and quanti-
tating their amount. Time is ripe to marry the two disciplines,
both in order to take lipidomics beyond the stage of ‘‘stamp
collection’’ [8] and in order to incorporate into the lipidology
approach the new knowledge about the individual lipid
species. I will illustrate my viewpoint in the present mini-
review by discussing the use of the old concepts of lipid shape
and membrane curvature in the context of trans-membrane
structure, membrane permeability, and enzymatic action. I
will go on to demonstrate how insights into lipid shape and
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applications within nano-medicine and drug delivery medi-
ated by liposomes. In particular I will show how lipids may
serve as prodrugs, pro-enhancers, and pro-permeabilizers
within liposomal drug delivery in cancer therapy [19, 20].
Curvature is a key concept in biology [21–24] although in
many cases overlooked by the life-science community.
Curvature is a so-called emergent property that arises as a
consequence of the complex and collective behavior of a large
numberofmolecules.Typically,curvatureisadynamicentity
that ﬂuctuates due to entropic forces, and in the case of
membranes it varies in time due to transient interactions
between the membrane and other cellular components, such
as proteins, solutes, as well as vesicles and other membranes.
In fact the entire cell, its membranes, organelles, and trans-
port systems are subject to stabilizing and destabilizing forces
that couple to curvature. An example is shown in Fig. 1 in the
case of intra-cellular trafﬁcking and the dynamical morpho-
genesis and maintenance of the Golgi apparatus [25].
Of the four main classes of macromolecules which make
up all types of biological systems: the carbohydrates, the fats,
the proteins, and the nucleic acids – the fats, e.g., the lipids,
distinguish themselves as molecules that in contrast to the
threeotherclassesarenotpolymersboundbycovalentforces.
Carbohydrates are poly-saccharides, proteins are poly-pep-
tides, and nucleic acids are poly-nucleotides. The lipids do
not form polymers under natural conditions, both rather self-
assemble into macromolecular aggregates in water in the
form of superstructures like micelles and lipid bilayers as
illustrated in Fig. 2. Of these structures, the closed lipid
bilayer in the form of a unilamellar vesicle or liposome is a
structure of fundamental importance for life since it is a
model of the lipid-bilayer component of cell membranes
[26–31]. A detailed visualization of the spontaneous for-
mation of an ensemble of self-assembled liposomes in a
suspension of lipid molecules in water is shown in Fig. 3.
Itistheself-assemblynatureoflipidbilayersthatholdsthe
key to both a fundamental understanding of lipid membrane
structure, dynamics, and function as well as to many tech-
nological applications of lipids. However, lipid self-assembly
and the complexity it imparts on lipid behavior is one of the
main sources for the difﬁculties associated with a quantitative
description of lipids in biology. A central dogma in molecular
biology is molecular structure and the relationship between
structure and function. This dogma has been a driving force
for the grand achievements of molecular biology during
the second part of the 20th century: the structure of the
double DNA helix and the structural characterization of
the gene products, the proteins. Speaking about structure
in this context, it is high-resolution structure with atomic
detail that is in focus. Although the importance of molecular
dynamics and heterogeneity as well as the inﬂuence of solvent
structure and dynamics on protein structure and function are
acknowledged, it is clear that the unraveling of a well-deﬁned
atomic structure has been the Holy Grail in molecular and
structural biology.
If one is looking for similar elements of molecular struc-
ture and order when it comes to lipids and membranes, one is
going to be disappointed. The hallmark of lipids in functional
membranes is just as much disorder as it is order. In fact the
balance between order and disorder is likely to be at the core
of regulation of biological function by lipids. However, dis-
order andthe wayorder emerges out ofdisorder isnot an easy
concept to grasp, and it requires methods from physics and
physical chemistry for dealing with in a quantitative manner.
This situation has implied that lipids until recent years have
been living in the shadow of the more fashionable study of
genes and proteins. Lipids were at best described by such
fuzzy terms as variability, diversity, plasticity, adaptability,
ﬂuidity,complexity,etc.,cf.Table1.Theseproperties,which
lipids share with other soft-matter materials, are all of col-
lective and emergent nature and in principle basic con-
sequences of the many-body nature of the lipid aggregates.
None of these collective properties are easy to deﬁne and
measure quantitatively and they are only related to the mol-
ecularandchemicalstructure oftheindividual lipidspecies in
rather subtle ways. However, as we shall see later, it is exactly
Figure 1. Schematic illustration of fusion and fission processes
involving transport processes of vesicles that are trafficking proteins
between the endoplasmic reticulum (bottom) and the Golgi appara-
tus (top). Courtesy of Dr. Matthias Weiss.
Figure 2. Schematic illustration of the self-assembly process of
lipids in water forming aggregates such as (a) a monolayer on the
air–water interface, (b) a lipid bilayer, (c) a micelle, (d) a unilamellar
liposome (vesicle), and (e) a multi-lamellar liposome.
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wide range of technological applications.
One of the outstanding mysteries in lipid cell biology is
lipid diversity, i.e., the fact that each type of membrane has a
very large number of different types of lipid species. As
information on the lipidome of various cells and subcellular
structures is accumulated it is becoming clear, that this diver-
sity is much larger than previously thought, and typically
several thousands of different lipids are found to be present
in each type of membrane. Considering the many ways all
these different species can arrange among themselves, it is
clear that the ‘‘language’’ or the ‘‘alphabet’’ of lipids is way
beyond the four-letter alphabet of the nucleotides used to
describe nuclei acids and the twenty-letter alphabet of the
aminoacidsused todescribeproteins.Theomics-languageof
lipids is thus far richer than previously anticipated thereby
exposing the full scope of the potential of what Rilfors and
Lindblom in 2002 coined ‘‘functional lipidomics’’ [32].
2 The powerful language of shape
The various lipid aggregates resulting from lipid self-assem-
bly processes as shown in Fig. 2 are only a few of the many
possible ones [33–37]. Others are shown in Fig. 4. It is
noteworthy that even topologically complex and highly
curved structures like hexagonal and cubic phases, as well
as a number of more disordered structures, are all found in
livingcellularsystems[21].Itshouldalsobenotedthatevenif
a particular non-lamellar and curved structure is not found as
an extended structure in a cell, it may well be so on a small
and local scale, such as in the context of fusion and ﬁssion
processes, cf. Fig. 1, as well as in the neighborhood of mem-
brane inclusions/proteins or in the form of membrane defects
such as pores. More importantly, amembrane may be subject
to instabilities due to intrinsic curvature stress and propensity
for forming curved structures.
It is possible qualitatively and in some cases semi-quan-
titatively to describe the lipid phase behavior via a simple
geometric property of the lipid molecule, the so-called
Israelachvili–Mitchell–Ninham packing parameter, P ¼
v/al, where v is the molecular volume, a is the cross-sectional
area of the head group, and l is the length of the molecule
[37]. Of course a lipid molecule in a dynamic lipid aggregate
cannot be assigned a shape as such, and the geometric
parameters v, a, and l should therefore be considered as
average properties. Still, the value of P turns out to be sur-
prisinglyusefulinpredictingthestructureofalipidaggregate.
Lipids with values of P not too close to unity are poor bilayer
Figure 3. Snapshots from a large-scale com-
puter simulation of the self-assembly process
of lipid vesicles (unilamellar liposomes) in
water based on dissipative particle dynamics
calculations [129]. The simulation box is
90 nm
3 and contains 50.000 lipid molecules
in water. The simulation covers a time span of
128 ms. Courtesy of Dr. Julian Shillcock.
Table 1. Some unique characteristics of soft-matter systems made
of lipids
Soft-matter characteristics of lipid systems
Bottom-up
Self-organized
Self-assembled
Versatile
Diverse
Plastic
Adaptable
Flexible
Complex
Fluid
Length-scale tunable
Durable
Self-repairing
Self-healing
1176 O. G. Mouritsen Eur. J. Lipid Sci. Technol. 2011, 113, 1174–1187
 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.ejlst.comformers. However, often the lipids in the two lipid monolayer
leaﬂets of a thermodynamically stable bilayer have, as illus-
trated in Fig. 5a and b, values of P different from unity and
hence suffer from a built-in curvature stress. Such mono-
layers would curve if they were allowed to do so and not being
conﬁned to constitute a stable bilayer. In some cases, the
effective value of P for a mixture of lipids with different values
of P can be estimated by a superposition principle, provided
that the lipid molecules are well mixed. As an example it is
possible to form stable bilayers of equimolar mixtures of
lysolipids and free fatty acids, that respectively have P<1
and P>1 [38–40]. Even in cases where the quantitative pre-
dictive power of the molecular packing parameter fails, it can
be useful in estimating the inﬂuence of a particular molecular
species on the stability of a given aggregate structure, e.g., the
destabilizing effect of conical molecules added to a lamellar
lipid bilayer. The packing parameter turns out to be linearly
related to the old concept of hydrophilic-lipophilic balance
(HLB) [41].
Theself-assemblednatureoflipidbilayersimpliesthatthey
are normally in a tension-less state. The most conspicuous
feature of a lipid bilayer is its transverse structure which is far
from that of an isotropic ﬂuid slab of hydrocarbons. It displays
a distinct lateral stress- or pressure proﬁle [42–45] as illus-
trated in Fig. 5c. The physics behind this proﬁle is based on
simple mechanics. In mechanical equilibrium in the tension-
less state, the integral of the difference between the normal
pressure and the lateral pressure, pN(z)–pL(z), has to become
zero. However, the variation of the lateral pressure across the
5 nm thick membrane goes from positive, expansive pressures
in the head group region, over regions of negative, tensile
pressuresintheinterfacialregions,toexpansive,positivepress-
ures in the acyl-chain region, as illustrated in Fig. 5c. These
variations can easily amount to the equivalent of hundreds of
atmospheres pressure. It is this very stressful environment
integral membrane proteins have to come to terms with.
In order to illustrate the potential of using molecular
shape as a simple means of predicting the effect of various
lipid species on the lateral pressure proﬁle of membranes, we
consider two types of molecules with different values of P:
unsaturated lipids which tend to have disordered and curly
chain conﬁgurations and hence P>1, and cholesterol which
has a small head group and a bulky hydrophobic body and
hence P<1. The unsaturated lipids are therefore expected to
move the pressures toward the membrane–water interface,
and this effect should increase with the degree of unsatura-
tion. In contrast cholesterol is expected to shift the pressures
Figure 4. Schematic illustration of lamellar and non-lamellar lipid
aggregates formed by self-assembly processes in water. The differ-
entstructureshavedifferentsensesofcurvatureandarearrangedin
accordance with thevalue of thephenomenological molecular pack-
ing parameter, P ¼ v/al, where v is the molecular volume, a is the
cross-sectional area of the head group, and l is the length of the
molecule. Adapted from [34].
Figure 5. (a) Lipid monolayers with negative, zero, and positive
(from left to right) curvature determined by the conicity of the lipid
molecules. (b) Stable lipid bilayer (middle) formed by two opposing
lipid monolayers. If the monolayers were not constrained by being in
the bilayer, they may want to curve as shown to the left and the right,
in which case the middle stable bilayer would suffer from a built-in
curvature stress. Courtesy of Dr. Olaf Sparre Andersen.
(c) Schematic illustration of the lateral pressure profile, p(z), of a
lipid bilayer, revealing regions of expansive (positive) pressures and
regions of large tensile (negative) pressures.
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Fig. 6 indeed supports these expectations [47]. These effects
imply dramatic changes in the curvature stress of the bilayer
and an increase in the ﬂip-ﬂop rate between the two mono-
layer sheets [48]. Possibly even more important, introduction
of an extra double bond in the acyl chain, speciﬁcally from
ﬁvetosix,hasasigniﬁcanteffectonthelateralpressureproﬁle
whereasitappearsonlytohaveamarginaleffectonotherbulk
bilayer properties [49]. Furthermore, the actual position of
the double bonds has a signiﬁcant effect on form of the lateral
pressure proﬁle [50]. All these ﬁndings are of importance for
the functioning of neural membranes which are rich in super-
unsaturated v-3 and v-6 fatty acids.
Lipid bilayers and membranes exhibit substantial struc-
ture in the plane of the membrane. This has been known for a
long time and has been described in terms like lipid domains
and lateral heterogeneity [51–54]. The lateral structure can
be induced by thermodynamically driven phase separation in
multi-component systems, lateral density and compositional
ﬂuctuations inequilibrium, non-equilibrium and steady-state
driven lateral organization in the active state, as well as
interactions between lipids and proteins. A particular import-
ant mechanism involves cholesterol which invariably is
involvedindomainorganizationinparticularinplasmamem-
branes [55]. Cholesterol is known to be the source of the so-
called liquid-ordered state of membranes [56, 57]. The inter-
est in the biological importance of lateral membrane hetero-
geneity and domains has been revived by the so-called raft
hypothesis [16, 58–60] that assumes differentiated small-
scale regions in biological membranes to be particular plat-
forms for a variety of cell functions, such as signaling and
different transport processes [14, 61].
The lateral structure may couple to curvature and enforce
the membrane to make both dynamic and static excursions in
the third dimension in the form of curved domains that may
develop into caps and buds [62–65]. An illustration of cap
formation on a giant unilamellar liposome is shown in Fig. 7.
The cap formation and the associated domain size are con-
trolled by a balance between the bulk free energies of the
different regions of the membrane and the line tension
around the cap. The ﬁnding of ﬁnite-size domains in vesicles
of lipid mixtures which otherwise would be expected to
undergo macroscopic phase separation has also been
described theoretically by a balance between the tendency
to form macroscopic phases, the line tension of the domains,
and a coupling to bilayer curvature [66].
As an example of the power of lipids with conical shape
(P 6¼ 1)toimpactonlipidbilayerpropertiesweshowinFig.8
how a fatty acid (P>1) can lower the permeability barrier of
lipid bilayers in the form of a closed liposome encapsulating
an anti-cancer drug, doxorubicin [67]. When integrating into
the lipid bilayer, the fatty acid increases the curvature stress
which leads to more leaky membranes. A similar behavior has
been found for a wide range of saturated and unsaturated
fatty acids as well as lysolipids which have the opposite sense
ofcurvature(P<1)[39,67–73].Lysolipidsalsopromotedrug
release, although less dramatically, probably because they are
more water soluble compared to a fatty acid with the same
Figure 7. Fluorescence microscopy image of a 17 mm giant unila-
mellar liposome composed of native pulmonary surfactants from pig
lung displaying fluid–fluid phase separation accompanied by cap
formation [130]. From www.scienceinyoureyes.com by courtesy of
Drs. Jorge Bernadino de la Serna and Luis A. Bagatolli.
Figure 6. Theoretical prediction of changes in the lateral pressure
profile of lipid bilayers that become incorporated with 1 mol% unsa-
turatedlipidsofdifferenttypesintoaDPPClipidbilayer.Thedataare
compared to the opposite changes induced by cholesterol incor-
poration. Courtesy of Dr. Robert S. Cantor.
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lysolipids affect liposomal permeability and how it depends
on the structure of the lipid bilayer (phase state, temperature,
thickness, etc.) is complex and not fully understood at
present. However,asweshall comebacktolater, theseeffects
can be exploited to release the payload of drugs in liposome-
based drug delivery.
3 Curvature stress and protein function
Proteins associated with membranes, both integral and per-
ipheral proteins, have to come to terms with the curvature
stresses in the bilayer [42, 74, 75]. In the case of integral
membrane proteins, the concept of hydrophobic matching
between the hydrophobic core of the lipid bilayer and the
hydrophobic stretch of integral membrane proteins has been
proposed [76–79] as a key determinant of lipid–protein inter-
actions as illustrated in Fig. 9a. Mismatch carries an energy
penalty which basically amounts to the elastic distortion of
the lipid matrix around the protein. For a sufﬁcient large
value of this penalty, the protein may yield and undergo a
conformationalchange,henceofferingamechanismforlipid-
mediated effects on protein function, as illustrated in Fig. 9b.
Hydrophobic matching provides in a membrane with several
types of lipid species the possibility of sorting, selection, or
enrichment of certain lipids near the protein [80, 81].
The hydrophobic matching and the induced membrane
curvature around the protein constitutes a mechanism for
lipid-mediated protein–protein interactions, typically attrac-
tive as illustrated in Fig. 9a, which will provide a driving force
for protein aggregation and possibly crystallization in the
plane of the membrane. The range of this protein–protein
interaction will be controlled by the coherence length of the
correlations between the lipids. This coherence length can be
very large in special parts of the phase diagram, in
particular close to critical points [82, 83, 84], and lead to
capillary-condensation phenomena and wetting around
proteins [85, 86].
The hydrophobic matching principle has been important
in substantiating the concept of membrane rafts [14], which
are domains enriched in cholesterol and high-melting lipids,in
particular sphingolipids, and therefore generally thicker than
the membrane matrix in which they reside. Matching then
furnishes a possible mechanism for protein selection where
those proteins, which match the raft thickness the better, e.g.,
via appropriate acylation or prenylation, are recruited to the
raft. Conversely they can be released from the raft by appro-
priate enzymatic modiﬁcation of the proteins. Hence, the
Figure 8. Percentage release as a function of time of doxorubicin
from 100 nm liposomes composed of POPC lipids upon addition of
20 mM palmitic acid [67]. Courtesy of Dr. Henrik Jespersen.
Figure 9. (a) Schematic illustration of the principle of hydrophobic
matching between lipid bilayers and integral membrane proteins. In
the case of a mismatch, the deformation in the lipid matrix may
induce an indirect, lipid-mediated attraction between the proteins.
(b) Schematic illustration of a conformational change in an integral
membraneproteininducedbychangesinthehydrophobicmismatch
condition(Adaptedfromref.3).(c)Releaseofthecurvaturestressin
a lipid bilayer, composed of two lipid monolayers with spontaneous
curvature, via the formation of the extended lipid chain conforma-
tion.Oneofthetailsofthelipidmoleculeiscapturedinahydrophobic
pocket of a peripheral membrane protein, e.g., cytochrome c.
Courtesy of Dr. P . K. J. Kinnunen. (d) Curvature stress may induce
conformational changes in a membrane channel and hence shift
the equilibrium between an open and a closed state. Courtesy of
Dr. O. S. Andersen.
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quantitative physical framework for signaling cascades.
The propensity of some lipids for inducing curvature
stress and possibly non-lamellar phases provides, via the
lateral pressure proﬁle, another mechanism for lipid–protein
interactions[45,87]asillustratedinFig.9b.Thismechanism
is not necessarily independent of the hydrophobic matching
mechanism. An illustration of this curvature-driven mechan-
ism is given in Fig. 9c and d respectively in the case of release
ofcurvaturestressbybindingaperipheralmembraneprotein,
such as cytochrome c [88], and a shift between two confor-
mations of a membrane channel, such as the opening and
closing of gramicidin A dimer channels [79]. Certain
proteins, e.g., the nicotinic acetylcholine receptor and the
voltage-dependent potassium channel may also have conical
shape[22] andthey therefore tendto arrangethemselves with
lipids that match this shape in order to maintain the lamellar
membrane structure. It is interesting to note that the total
lipidextract ofmanyplasmamembranes donotformlamellar
phases when suspended in water solution indicating that
proteins and lipids exhibit some kind of shape compensation
in intact biological membranes.
Most of the quantitative, fundamental insight into mem-
brane structure, dynamics, and molecular organization has
been obtained from various model studies, experimentally as
well as theoretically, and they almost invariably refer to sys-
tems in or near thermodynamic equilibrium [31]. However,
functioning biological membranes are not in equilibrium but
are constantly subject to exchange of energy and material
with the environment or are being modulated by active
proteinsandenzymesthat areassociatedwiththemembranes
[89]. This association often involves coupling between the
protein and the membrane curvature or the stress ﬁelds of the
lipid bilayer. It is well known from statistical physics that the
properties of non-equilibrium systems are fundamentally
different from their equilibrium counterparts, e.g., new levels
of organization arise in driven-diffusive systems, and order
may emerge out of disorder due to an external drive [90].
A quantitative study of the physical properties of model
membranes out of equilibrium is extremely difﬁcult. Hence
the results of only few studies have been published [91–100].
A typical example is a membrane with an ion pump that is
driven by some kind of energy transduction mechanism
[96, 101]. Another example is the binding of ligands to
receptors where the binding is inﬂuenced by a force, e.g.,
thebindingofcollectinsintheinnateimmunesystemtosugar
groups on invading pathogens [102]. A third example is the
set of responsive membranes in the dermal barrier that is
subject to a gradient in water chemical potential [103]. A
fourth example is the morphogenesis of the endoplasmatic
reticulum and the Golgi apparatus with membranes that owe
their existence to non-equilibrium conditions of ﬂow of
energy and matter [25]. It is interesting in this context to
note that the plasma membrane can undergo phase separ-
ation when the cell dies and the activity comes to a stop [14].
4 Peripheral proteins and enzymes that sense
curvature
A range of important biological functions mediated by
membranes appear to be partly or fully controlled by local
membrane curvature [23]. Examples include membrane-
curvature control of dynamin polymerization [104], phos-
phocholine cytidylyltransferase activity [105], and the bind-
ing of bar domains to membrane surfaces [22, 23, 106, 107]
as illustrated in Fig. 10. This ﬁgure also indicates that the
action of many enzymes and drugs, e.g., amphiphatic and
antibiotic peptides [107, 108], is mediated by coupling to
membrane curvature which in some cases induces morpho-
logical alterations at and in the membrane.
A particular class of enzymes acts on membranes
by degradating phospholipids or sphingolipids, e.g.,
phospholipase A2 (PLA2), phospholipase C, and sphingo-
myelinase. These enzymes remodel the membranes by pro-
ducing products that may have propensity for forming non-
lamellar, curved lipid structures. Speciﬁcally PLA2 generates
lysolipids and free fatty acids, and phospholipase C generates
di-acyl glycerol, as illustrated schematically in Fig. 11.
Sphingomyelinase produces ceramide which is known to lead
to pronounced membrane curvature and blebbing, a
phenomenon that has been associated with apoptosis [109].
Extensivestudieshavebeencarriedoutinordertounravel
the mechanism of secretory phospholipase A2 (s-PLA2)
action on lipid bilayers of different composition and under
different physico-chemical conditions [110, 111, 112].
s-PLA2 is only active at lipid interfaces and not on lipid
monomers in solution. Moreover, it turns out that its enzy-
mologyisratherpeculiarinthesensethattheenzymedisplays
a so-called lag-burst behavior, as illustrated in Fig. 12. The
lag-time turns out to be extremely sensitive to the physical
state of the bilayer substrate, in particular its lateral hetero-
geneity and defect structure. The more defects and hetero-
geneity, the shorter the lag-time. The heterogeneities in turn
can be controlled by a long list of factors, including tempera-
ture, composition, phase transitions, phase separations, com-
positional and density ﬂuctuations, as well as edge effects.
Figure 10. Schematic illustration of proteins and peptides that
sense membrane curvature and lipid packing. (a) Bar domain that
bindtomembraneregionswithhighcurvature. (b)Amphiphatichelix
that respond to lipid packing. (c) Protein with hydrophobic anchors
thatsenselipidpacking.(d)and(e)Enzymes,suchasproteinkinase
C or PLA2, with high activityat curved membranes and loweractivity
at planar membranes. Courtesy of Dr. D. Stamou, reproduced with a
permission of the publisher [106].
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defects with high curvature and associated with enhanced
lipidprotrusionmodes[113,114]thatwilltriggertheenzyme
activity. The heterogeneity is further enhanced by the
hydrolysis products that lead to increased curvature stress
and local defects in the bilayer. In this way the enzyme
autocatalyzes its own activity which eventually leads to the
burst in activity.
The important lesson from these studies is that s-PLA2 is
extremely sensitive to the structure and physical properties of
the lipid bilayer substrate, in particular local curvature and
defects. The enzymatic action leads to a remodeling of the
membrane [112]. This observation can be exploited when
constructing liposomal drug-delivery systems tailored to be
sensitive to enzymatic breakdown and subsequent localized
drug release in cancerous tissue which is characterized by
elevated levels of s-PLA2. We shall address this in further
detail below.
A particular way of activating s-PLA2 on liposomal sur-
faces was somewhat surprisingly discovered in studies of the
activity on lipid bilayers incorporated with lipopolymers
which are lipids to whose head group is covalently linked a
water-soluble polymer, typically poly-ethylene-glycol (PEG).
It turns out that s-PLA2 is more active on such surfaces
compared to naked lipid bilayers. Furthermore, the activity
is stronger, i.e., the lag-time is shorter, the larger the surface
coverage of the polymers is and the longer the polymer chains
are [115]. The explanation of this phenomenon is an entropic
pull on the lipopolymers which tends to enhance the protru-
sion modes of the neighboring lipid molecules rendering
them more prone for attack of the lipase. The entropic pull
is caused by the conﬁnement of the water-soluble PEG chain
which cannot penetrate the membrane leading to a decrease
in the conformational entropy of the chain. To compensate
for the corresponding loss in free energy, the lipopolymer
tends to be displaced somewhat into the aqueous compart-
ment [113]. Hence, the physico-chemical properties of the
PEGylated lipids offer themselves as another control
parameter for regulation of the enzyme activity.
5 Liposomal drug-delivery systems with
enzymatic triggering via curvature stress
We will now show how it is possible to combine the insight in
curvature stress and the physical chemistry of lipid bilayers
withanunderstanding ofthemechanismofactivatings-PLA2
in order to construct a liposomal drug-delivery system that
may remove a critical bottleneck in the use of liposomes for
cancer therapy. The resulting delivery system is hence con-
structed on the basis of fundamental principles of physical
chemistry and physical enzymology. This approach to drug
research, which already has been subject to phase-I clinical
trails, is unconventional in the sense that it is predominantly
based on physical sciences and the concept of membrane
curvature stress rather than medicinal chemistry and
traditional drug-receptor considerations.
The proposed system takes advantage of the speciﬁc
biophysical properties of the lipid bilayer [116, 117] of lip-
osomes on the one side and the peculiar pathophysiological
and biochemical properties of cancer cells on the other side.
Thereby it becomes possible to passively target liposomes to
diseased cells and with a particular mechanism, involving
endogenously upregulated s-PLA2, to open the liposomal
carriers and unload the drug precisely where the drug is
supposed to act. It is furthermore possible to construct the
liposomes of speciﬁc lipids that upon phospholipase-assisted
hydrolysis are turned into products that may act as enhances,
as permeabilizers, and even as drugs themselves [118–120].
Liposomes for drug delivery are usually protected from
the human immune system by a polymer coat made up of
PEG moieties that are covalently linked to the head group of
charged lipids, such as DSPE or DSPS, cf. Fig. 13. This type
of PEGylation, which is the basis of the so-called stealth
liposomes [121], has two important consequences. Firstly,
Figure 12. Lag-burst behavior of s-PLA2 acting on a lipid bilayer
substrate. Upon addition of the enzyme a characteristic lag period
follows during which very little activity can be discerned. After a lag-
time t a sudden burst of activity sets in. The activity can be mon-
itored, e.g., by detection of intrinsic tryptophan fluorescence.
Figure 11. Formation of conically shaped molecules by enzymatic
action. (a) PLA2 generates lysolipids and free fatty acids.
(b) Phospholipase C generates di-acylglycerol by chopping off the
head group of the lipid.
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venous administration in theblood stream, hence limiting the
systemic side effects of the drug. Secondly, it leads to
increased circulation lifetimes and hence enhances the like-
lihood for liposomes of appropriate size, typically 100 nm, to
venture into the capillary network of, e.g., solid tumors. The
tumor vasculature is often rather fenestered and since the
lymphaticdrainageofthetumorsissuppressedincomparison
with that in healthy tissue, liposomes tend to accumulate in
thetumor.Thiseffectiscalledtheenhancedpermeabilityand
retention (EPR) effect.
It has been known for some time that liposomal drug-
delivery systems can limit systemic side effects and one of the
successful formulations is Doxil [122] which are stealth lip-
osomes with doxorubicin approved for treating, e.g., ovarian
cancer. A paradoxical limitation of the efﬁcacy of the lip-
osomes including Doxil is that their stability turns into a
disadvantage at the target where the drug has to be unloaded
and in many cases the unloading of the drug is very poor.
Hence an effective trigger mechanism for discharging the
payload is called for.
One such trigger mechanism is the use of heating the
tumor in the case where the liposomes have been made
thermosensitive, e.g., by having a phase transition that is a
few degrees above physiological temperatures [123, 124]. At
the phase transition, the lipid bilayer of the liposomes
becomes leaky [8] and the drug can escape into the tumor
tissue. The thermal triggering mechanism requires that the
tumor can be localized and heated by external heating devi-
ces.Asystemofthistypeiscurrentlyinphase-IIIclinicaltrials
for treatment of liver cancer [124].
Another possible trigger mechanism is the use of
endogenously upregulated s-PLA2 to destroy the liposomes
at target. In turns out that many different kinds of tumors,
e.g., breast, colon, gastric, pancreas, lung, liver, and prostate
cancer, have such upregulated type IIA s-PLA2 in a local
concentration in the tumor that is one or two orders of
magnitude larger than serum levels and much higher than
in the healthy tissue lining the tumor [125–127].
Stealth liposomes that have been made sensitive to
hydrolysis by s-PLA2 have been coined LiPlasomes. These
lipase-labile liposomes have been proposed as suitable
carriers for drugs targeted to tumors with locally high levels
of s-PLA2 activity [20, 117]. The development and design of
the LiPlasomes is based on years of extensive studies of lipid
bilayers and model membranes and how the activity of s-
PLA2 on these lipid systems can be controlled by the physical
properties and qualities of the lipid bilayers [110].
LiPlasomes have been tested on a variety of in vitro cell
cultures of cancer cell lines that secrete s-PLA2 [20] with
encapsulated anti-cancer drugs like doxorubicin, cisplatin,
and 5-FU (ﬂuorouracil), and in all cases it has been found
that LiPlasomes poised to unload the drugs by s-PLA2 action
limit the cell growth whereas conventional liposomes are
much less effective. The crucial next step involves in vivo
studies on mice, and Fig. 14 shows as an example that
cisplatin-loaded LiPlasomes are very effective to limit the
growth of human xenograft MT-3 breast cancer in mice.
This encouraging in vivo proof-of-principle was the basis
for bringing the ﬁrst dose of LiPlasomes in man.
It is noteworthy from Fig. 14 that the mice treated with
LiPlasome formulations with cisplatin are not only doing
much better than the control group; in fact they do better
than the group of mice treated with the free drug at similar
toxic doses.
A plausible reason for this remarkable effect becomes
clear when considering the action of s-PLA2 on the
LiPlasomal carrier. The enzyme not only opens the capsule
by hydrolyzing the lipids. It also releases the hydrolysis prod-
ucts, lysolipids and free fatty acids, as illustrated in Fig. 11a.
As wedescribed above and illustrated in Fig. 8 these products
act as enhancers and permeabilizers because they induce
curvature stress in the target membranes of the cancer cells,
thereby lowering the permeability barrier and facilitating the
transport of the active drugs into the cells. In this way the
phospholipids of the liposomal carrier have acted not only as
materials for the liposome; they have also performed as pro-
enhancers and pro-permeabilizers that are turned into
enhancers and permeabilizers exactly where they are needed.
6 Afuturisticscenarioinnano-medicine:Lipid
prodrugs
Once it has been established that it is possible to construct
LiPlasomes which are stable in the blood stream, which
accumulates in the diseased tissue, and whose drug load
can be released by endogenously upregulated s-PLA2; and
Figure 13. Schematic illustration of a stealth liposome with a poly-
mer coat of PEG that screens the liposome from the native immune
system in the blood stream.
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act as enhancers and permeabilizers; a scenario suggests itself
by which the lipids in the liposomal carrier themselves are
prodrugs which by s-PLA2 action are turned into active drugs
precisely at the target. In principle, by this scenario the
LiPlasomes could be empty and seen as a magic bullet, the
LiPlasome acting at the same time both as a carrier and as a
drug. Needless to say, such LiPlasomes could also be loaded
withconventionaldrugssuchasdoxorubicinorcisplatintobe
used in a special type of combination therapy.
The ﬁrst type of prodrug lipids that come to mind are
mono-ether-mono-ester glycerol-phospholipids, in which the
sn-1 chain is linked to the glycerol backbone by an ether
linkage and the sn-2 chain by an ester linkage [128]. Upon
s-PLA2 action, a lysoetherlipid and a free fatty acid are
released. Certain types of lysoetherlipids are known to be
strongly cytotoxic, but since the red blood cells lack enzymes
to degradate these etherlipids, injection of such compounds
in the blood stream leads to massive hemolysis. Cancer cells
are also not able to break down the etherlipids and their
membranes will be massively damaged by the compounds.
Hence a unique possibility opens for using lysoetherlipids to
treat cancer by tugging the hemolytic etherlipid away in a
mono-ether-mono-ester phospholipid compound. As long as
the etherlipid remains bound in this compound it turns out
not to be hemolytic [128]. However, once it is released by
s-PLA2 action in the tumor tissue it can act. The feasibility of
this mechanism has been demonstrated by in vitro studies on
gastric cancer cell cultures that secrete s-PLA2.
Weare now ready to make a further step andconsider also
making the entity linked to the phospholipid on the sn-2
position a potential drug, i.e., a prodrug that is turned into
an active drug upon release by s-PLA2 action in the cancer
tissue. This new type of phospholipid consisting of an lysoe-
therlipid and another active lipid drug substance can be
considered a double lipid prodrug.
We have successfully synthesized a series of such double
lipid prodrugs, with an etherlipid at the sn-1 position and
potent drugs like chlorambucil [118] or derivatives ofretinoic
acid [119, 120] on the sn-2 position. An illustration of this
double lipid prodrug principle in a liposomal formulation is
provided in Fig. 15. The efﬁcacy of these lipid prodrug
systems has been evaluated in a number of different in vitro
cell culture studies of various human cancer cell lines and it is
found that the combination of the two lipid drugs enhances
the cytotoxicity.
The further development of such double lipid prodrug
systems requires optimization with respect to choice of both
the actual active chemical components that are built into the
lipids and the other lipid constituents of the liposome. Not all
constructs will lead to stable liposomes. However, it is
possible to secure liposome stability and optimize suscepti-
bility to s-PLA2 action by premixing with other lipid species
that do not act as drugs but facilitate the liposome formation
and possibly even enhances the enzymatic breakdown of
prodrugs [120]. In this way a dilution of the prodrug may
be amply outbalanced by a more effective turnover of the
prodrugs into drugs. Finally, combination formulations
including an encapsulated conventional drug should also
be considered.
7 Concluding remarks
The concepts of lipid shape and packing, membrane curva-
ture and curvature stress, as well as the lateral stress proﬁle of
lipid bilayers are not new concepts but their potential for use
in developing novel types of nano-medicine should not be
neglected. Even if these concepts in some cases are less well
deﬁned and possibly even difﬁcult to measure and describe
quantitatively they can serve as valuable guides for shaping
theintuitionthatisnecessary tomobilizeforinnovation inthe
treatment of serious diseases.
The present mini-review has illustrated how an insight
into the basic physical chemistry of lipids, including their
many seemingly fuzzy characteristics listed in Table 1,
together with an understanding of the peculiar enzymology
of interfacially activated phospholipases may provide a basis
for a rational approach to liposome-based nano-medicine.
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Figure 14. In vivo proof of principle of the efficacy of LiPlasomes
loaded with cisplatin applied to a human xenograft MT-3 breast
cancer in mice. Data from LiPlasome Pharma A/S.
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